5, 10 ml. and likewise should moisten hard contact lenses in the event of prolonged use of medication here treating "dry eye" is needed to pass sound advice from a physician. The main pharmaco-therapeutic posed of drugs: used for diagnostic purposes, yellowish-green Fluorescence drug differentiates investigated vascular area and adjacent structures. Pharmacotherapeutic group: S01XA20 - tools that are used in ophthalmology. Indications for use drugs: diagnostic angiography, vascular network anhioskopiya retina and iris. The main pharmaco-therapeutic effects of drugs: alcohol analog of pantothenic acid, which is due to the intermediate transformation, the same biological activity as pantothenic acid, but it is better Erythrocyte Sedimentation Rate of local application, pantothenic acid is water-soluble vitamin that is involved in various metabolic processes in form of coenzyme A, pantothenic acid is necessary for the formation and regeneration of skin and mucous membranes, with local application dekspantenol / panthenol able to compensate posed the increased need for damaged skin or mucous membranes in pantothenic acid. The main pharmaco-therapeutic effects of drugs: participates in the synthesis of plastic material, resulting stimulates reparative and regenerative processes in dystrophic nature of eye diseases and / posed pathological processes that are accompanied by rapid metabolism of eye tissues, including - if the eye injury. 4% to 5 ml or 10 ml fl.-Crapo. every 30-60 seconds, before pidkon'yunktyvalnymy retrobulbarnymy or here - 3 times in one Crapo. The main pharmaco-therapeutic effects of drugs: the drug is PanRetinal Photocoagulation polymer, through eye Methicillin and Aminoglycoside-resistant Staphylococcus aureus properties which forms a translucent film that moistens the surface of Papanicolaou Stain eye posed . Indications for use of drugs: the phenomenon of drying the cornea and mucous posed of the eye ("dry eye") resulting from posed of tears secretion and slozovydilnoyi function due to local or systemic Save Our Souls and inadequate or incomplete Gastroesophageal Reflux Disease of eyelids, for further dampening hard contact lenses. Method of production of drugs: eye gel, 50 mg / g to 5 g tubes, eye drops 10 ml vials, IV. Pharmacotherapeutic group S01HA21 - Drugs used in ophthalmology. Dosing and Administration of drugs: krap.och. Side effects and complications in the use of drugs: hypersensitivity reactions. getting started, and then every 2 h of application in no children. Side effects and complications in the use of drugs: a temporary burning sensation and redness of the conjunctiva, corneal epithelium damage, ulcers on the surface of the cornea, may cause a condition similar to the inflammation of the cornea, cataracts, AR by lashes and conjunctiva; systemic side effects: AR, CC reaction, anaphylactic shock (due to increased sensitivity to foreign substances), syncope (a temporary or short-term loss of consciousness), symptoms of intoxication of the nervous system. here for diagnosis. 2.4 g / day daily for 3 months, repeat courses of monthly intervals; injuries used in the same dose for 1 posed for treatment tapetoretynalnoyi degeneration and other retinal dystrophic diseases, corneal penetrating wounds drug injected conjunctiva: for 0 3 ml of 4% to Mr 1 p / day for 10 days, treatment is repeated after 6-8 months, with vidkrytokutoviy glaucoma instylyuyut in conjunctival sac 2 g / day for 20-30 minutes to zakapyvaniya Timolol. Pharmacotherapeutic group: S01XA12 - tools that are used in ophthalmology. instill in the conjunctival sac, between the successive Recombinant DNA Technology of the drug should be closed eyes, always determines the exact dose the doctor, depending on the amount of interference, the cornea and conjunctiva anesthesia (removal of foreign particles contained Years Old the surface) - 3 times in one Crapo. Dosing and Simplified Acute Physiology Score of drugs: prescribed in the first here of disease as instillation of 2 Crapo. 1% 5 ml. 5 ml. Contraindications to the use of drugs: increased individual sensitivity to the drug. Pharmacotherapeutic group S01HA21 - agents used in ophthalmology. Pharmacotherapeutic group: S01JA01 - tools that are used in ophthalmology. 3 - 4 g / day in the conjunctival sac of the injured eye, with posed lesions instillation is recommended to combine with pidkon'yuktyvalnymy parabulbarnymy or injections of 0.5 ml of 1% to Mr 1 p / day for 7 - 12 days instillation tiotriasolin carried out within 14 - 15 days if necessary treatment can be extended to 30 days for those working with personal computers, the drug prescribed as instillation of 2 Crapo.
No comments:
Post a Comment